Breast Cancer Biomarkers as a Clinical Management Tool - Licensing Opportunity from Royal College of Surgeons in Ireland - November 2015 front page preview

Breast Cancer Biomarkers as a Clinical Management Tool - Licensing Opportunity from Royal College of Surgeons in Ireland - November 2015

Currently women diagnosed with breast cancer generally undergo surgery to remove the tumour. Many will also receive either chemo or radiotherapy or a combination of both. Approximately two thirds of all breast cancers ...

pdf 375.9KB

Novel companion diagnostic and  treatment for metastic breast cancer disease - Licensing Opportunity from Royal College of Surgeons in Ireland - November 2015 front page preview

Novel companion diagnostic and treatment for metastic breast cancer disease - Licensing Opportunity from Royal College of Surgeons in Ireland - November 2015

Endocrine therapies are the treatment of choice for over 70% of breast cancer patients, however 40% will relapse and develop metastatic disease. Metastasis is the prime cause of cancer patient mortality. There is curren...

pdf 383.4KB

Osteoporotic Bone Manipulating Device - Licensing Opportunity from Royal College of Surgeons in Ireland - November 2015 front page preview

Osteoporotic Bone Manipulating Device - Licensing Opportunity from Royal College of Surgeons in Ireland - November 2015

A multi-disciplinary team of orthopaedic surgeons and engineers at the Royal College of Surgeons in Ireland have developed, patented and clinically tested a new Osteoporotic Bone Manipulator device that protects weak ost...

pdf 219.5KB

Diagnostic Biomarker Assay Maturity-Onset of Diabetes of the Young (MODY) - Licensing opportunity from Royal College of Surgeons in Ireland - November 2015 front page preview

Diagnostic Biomarker Assay Maturity-Onset of Diabetes of the Young (MODY) - Licensing opportunity from Royal College of Surgeons in Ireland - November 2015

The HNF1α-MODY diagnostic assay provides a new sensitive blood test that enables clinicians to more accurately identify cases of MODY and deliver the most appropriate treatment and prevent chronic diabetic complications ...

pdf 218.4KB

Dose Response Medical Outcome Model Predictor System - licensing opportunity from Royal College of Surgeons in Ireland - November 2015  front page preview

Dose Response Medical Outcome Model Predictor System - licensing opportunity from Royal College of Surgeons in Ireland - November 2015

Aware of the need to personalise cancer treatment programmes in order to more effectively kill cancer cells while preserving healthy tissue, researchers at RCSI have developed a Dose Response Medical Outcome Model Predic...

pdf 320.9KB